Skip to content

Makerere University Walter Reed Program

Home
About MUWRP
Research
PEPFAR
Emerging Diseases
News and Resources
- News
- Newsletters
Careers

Search for:

Home
Uncategorized
MUWRP Partners With Sabin Vaccine Institute to Conduct Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

MUWRP Partners With Sabin Vaccine Institute to Conduct Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

Richard Mayanja July 16, 2024

Phase2_Clinical_Trial_Marburg_Sabin_MUWRP_Kampala_Uganda_042-1500x1000-6b42342-aspect-ratio-990-715-1

The Makerere University Walter Reed Project (MUWRP) is pleased to partner with the Sabin Vaccine Institute to conduct a phase 2 clinical trial for Sudan Ebolavirus vaccine. Below is a full statement from the Sabin Vaccine Institute on this development:

https://www.sabin.org/resources/sabin-vaccine-institute-begins-phase-2-clinical-trial-for-sudan-ebolavirus-vaccine

Continue Reading

Previous: MUWRP bids farewell to Dr. Vamsi Vasireddy

Next: Advancing HIV Prevention through a Discrete Choice Experiment at MUWRP

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Related Stories

Interview session

Advancing HIV Prevention through a Discrete Choice Experiment at MUWRP

Richard Mayanja October 18, 2024

Vamsi-MUWRP4-3

MUWRP bids farewell to Dr. Vamsi Vasireddy

Richard Mayanja July 12, 2024

Ambasador-commissions-boat-2

MUWRP Commissions A New Boat to Enhance Health Care Access in Koome and Buvuma Islands

Richard Mayanja July 9, 2024

Latest News

Advancing HIV Prevention through a Discrete Choice Experiment at MUWRP
MUWRP Partners With Sabin Vaccine Institute to Conduct Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

Makerere University Walter Reed Program Follow

MUWRP is a Leading Biomedical Research Organization, advancing healthcare and biomedical research.

Makerere University Walter Reed Program @muwrp_ ·

18 Dec

The month of December, beginning with World AIDS Day, serves as an important time for worldwide contemplation and a renewed dedication to intensifying efforts to end AIDS. Below, we share special messages from #MUWRP's leadership that underscore our contribution to this endeavor:

4

Reply on Twitter 1869385856534139183 Retweet on Twitter 1869385856534139183 1 Like on Twitter 1869385856534139183 5 X 1869385856534139183

Makerere University Walter Reed Program @muwrp_ ·

24 Oct

1/2: On October 15, 2024, @MUWRP_ leadership made a courtesy visit to the Joint Staff Health Services of the @MODVA_UPDF and toured their new biosafety-level 2 (BSLII) infectious diseases laboratory, at Mbuya, Kampala

Reply on Twitter 1849424511034126366 Retweet on Twitter 1849424511034126366 Like on Twitter 1849424511034126366 X 1849424511034126366

Makerere University Walter Reed Program @muwrp_ ·

24 Oct

The Emerging Infectious Diseases Program team from @MUWRP_ is currently conducting a two-week experiential training on #AntimicrobialResistance (#AMR) at @kirudduNRH for health workers from #GuluRRH, #BomboGeneralMilitaryHospital and #BweraHospital - from 14 - 25, October 2024.

Reply on Twitter 1849418880021569628 Retweet on Twitter 1849418880021569628 Like on Twitter 1849418880021569628 8 X 1849418880021569628

Makerere University Walter Reed Program @muwrp_ ·

18 Oct

Maiya Block Ngaybe, MPH, a National Institutes of Health Fogarty Global Health Equity Scholar affiliated with the University of Arizona, was hosted by @MUWRP_ this past year for her dissertation research. See findings from the research in this report:

Reply on Twitter 1847252504452452608 Retweet on Twitter 1847252504452452608 Like on Twitter 1847252504452452608 8 X 1847252504452452608

Load More

| MoreNews by AF themes.